TrialHepatology international2024
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan.
Chao-Wei Hsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it